ResMed Inc. (0KW4.L)
USD 213.63
(2.92%)
USD 213.63
(2.92%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 822.25 Million USD | -17.61% |
| 2023 | 998.01 Million USD | 34.16% |
| 2022 | 743.91 Million USD | 62.77% |
| 2021 | 457.03 Million USD | 9.62% |
| 2020 | 416.91 Million USD | 19.24% |
| 2019 | 349.64 Million USD | 30.12% |
| 2018 | 268.7 Million USD | 0.14% |
| 2017 | 268.31 Million USD | 19.54% |
| 2016 | 224.45 Million USD | -9.08% |
| 2015 | 246.85 Million USD | 49.23% |
| 2014 | 165.41 Million USD | 13.42% |
| 2013 | 145.84 Million USD | -16.35% |
| 2012 | 174.35 Million USD | -13.16% |
| 2011 | 200.77 Million USD | 8.15% |
| 2010 | 185.64 Million USD | 17.92% |
| 2009 | 157.43 Million USD | -0.52% |
| 2008 | 158.25 Million USD | 0.67% |
| 2007 | 157.2 Million USD | 35.29% |
| 2006 | 116.19 Million USD | 30.4% |
| 2005 | 89.1 Million USD | 59.7% |
| 2004 | 55.79 Million USD | 12.98% |
| 2003 | 49.38 Million USD | 19.95% |
| 2002 | 41.17 Million USD | 37.27% |
| 2001 | 29.99 Million USD | 89.81% |
| 2000 | 15.8 Million USD | 47.68% |
| 1999 | 10.7 Million USD | 40.79% |
| 1998 | 7.6 Million USD | 31.03% |
| 1997 | 5.8 Million USD | -4.92% |
| 1996 | 6.1 Million USD | 38.64% |
| 1995 | 4.4 Million USD | 340.0% |
| 1994 | 1 Million USD | 0.0% |
| 1993 | 1 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 FY | 822.25 Million USD | -17.61% |
| 2024 Q1 | 958.23 Million USD | -3.99% |
| 2024 Q2 | 933.21 Million USD | -2.61% |
| 2024 Q4 | 822.25 Million USD | -0.87% |
| 2024 Q3 | 829.45 Million USD | -11.12% |
| 2023 Q3 | 1.01 Billion USD | 2.26% |
| 2023 FY | 998.01 Million USD | 34.16% |
| 2023 Q1 | 864.85 Million USD | 16.26% |
| 2023 Q2 | 988.95 Million USD | 14.35% |
| 2023 Q4 | 998.01 Million USD | -1.31% |
| 2022 Q3 | 664.94 Million USD | 12.29% |
| 2022 Q1 | 506.64 Million USD | 10.86% |
| 2022 Q2 | 592.14 Million USD | 16.88% |
| 2022 FY | 743.91 Million USD | 62.77% |
| 2022 Q4 | 743.91 Million USD | 11.88% |
| 2021 Q1 | 478 Million USD | 14.65% |
| 2021 FY | 457.03 Million USD | 9.62% |
| 2021 Q2 | 474.82 Million USD | -0.67% |
| 2021 Q3 | 484.06 Million USD | 1.95% |
| 2021 Q4 | 457.03 Million USD | -5.58% |
| 2020 FY | 416.91 Million USD | 19.24% |
| 2020 Q2 | 377.78 Million USD | 5.81% |
| 2020 Q3 | 358.77 Million USD | -5.03% |
| 2020 Q4 | 416.91 Million USD | 16.21% |
| 2020 Q1 | 357.03 Million USD | 2.11% |
| 2019 Q1 | 282.55 Million USD | 5.16% |
| 2019 Q3 | 319.93 Million USD | 7.9% |
| 2019 Q2 | 296.51 Million USD | 4.94% |
| 2019 Q4 | 349.64 Million USD | 9.29% |
| 2019 FY | 349.64 Million USD | 30.12% |
| 2018 Q1 | 300.47 Million USD | 11.98% |
| 2018 Q4 | 268.7 Million USD | -6.93% |
| 2018 Q3 | 288.7 Million USD | -2.49% |
| 2018 FY | 268.7 Million USD | 0.14% |
| 2018 Q2 | 296.06 Million USD | -1.47% |
| 2017 Q2 | 253.1 Million USD | -0.28% |
| 2017 Q1 | 253.82 Million USD | 13.09% |
| 2017 Q4 | 268.31 Million USD | 3.25% |
| 2017 FY | 268.31 Million USD | 19.54% |
| 2017 Q3 | 259.87 Million USD | 2.67% |
| 2016 Q4 | 224.45 Million USD | -3.64% |
| 2016 FY | 224.45 Million USD | -9.08% |
| 2016 Q2 | 237.46 Million USD | -8.18% |
| 2016 Q1 | 258.6 Million USD | 4.76% |
| 2016 Q3 | 232.93 Million USD | -1.91% |
| 2015 Q1 | 197.22 Million USD | 19.23% |
| 2015 FY | 246.85 Million USD | 49.23% |
| 2015 Q2 | 218.06 Million USD | 10.56% |
| 2015 Q3 | 225.19 Million USD | 3.27% |
| 2015 Q4 | 246.85 Million USD | 9.62% |
| 2014 FY | 165.41 Million USD | 13.42% |
| 2014 Q1 | 175.35 Million USD | 20.23% |
| 2014 Q3 | 164.88 Million USD | -7.41% |
| 2014 Q4 | 165.41 Million USD | 0.32% |
| 2014 Q2 | 178.07 Million USD | 1.55% |
| 2013 Q2 | 194.8 Million USD | 0.84% |
| 2013 Q1 | 193.17 Million USD | 10.79% |
| 2013 Q4 | 145.84 Million USD | -12.4% |
| 2013 FY | 145.84 Million USD | -16.35% |
| 2013 Q3 | 166.48 Million USD | -14.54% |
| 2012 Q3 | 183.48 Million USD | -0.51% |
| 2012 Q4 | 174.35 Million USD | -4.98% |
| 2012 Q2 | 184.42 Million USD | -1.88% |
| 2012 FY | 174.35 Million USD | -13.16% |
| 2012 Q1 | 187.95 Million USD | -6.39% |
| 2011 FY | 200.77 Million USD | 8.15% |
| 2011 Q2 | 214.88 Million USD | 0.32% |
| 2011 Q3 | 205 Million USD | -4.6% |
| 2011 Q4 | 200.77 Million USD | -2.06% |
| 2011 Q1 | 214.2 Million USD | 15.39% |
| 2010 FY | 185.64 Million USD | 17.92% |
| 2010 Q2 | 182.87 Million USD | 4.43% |
| 2010 Q1 | 175.1 Million USD | 11.23% |
| 2010 Q3 | 197.81 Million USD | 8.17% |
| 2010 Q4 | 185.64 Million USD | -6.15% |
| 2009 Q4 | 157.43 Million USD | 6.61% |
| 2009 FY | 157.43 Million USD | -0.52% |
| 2009 Q3 | 147.67 Million USD | 3.22% |
| 2009 Q2 | 143.06 Million USD | -1.74% |
| 2009 Q1 | 145.59 Million USD | -8.0% |
| 2008 Q4 | 158.25 Million USD | -6.63% |
| 2008 Q2 | 166.4 Million USD | -0.4% |
| 2008 Q1 | 167.07 Million USD | 6.28% |
| 2008 FY | 158.25 Million USD | 0.67% |
| 2008 Q3 | 169.48 Million USD | 1.85% |
| 2007 Q4 | 157.2 Million USD | 0.18% |
| 2007 FY | 157.2 Million USD | 35.29% |
| 2007 Q3 | 156.91 Million USD | 10.6% |
| 2007 Q2 | 141.87 Million USD | 15.38% |
| 2007 Q1 | 122.96 Million USD | 5.83% |
| 2006 Q2 | 107.52 Million USD | 6.58% |
| 2006 Q3 | 108.74 Million USD | 1.14% |
| 2006 Q4 | 116.19 Million USD | 6.85% |
| 2006 FY | 116.19 Million USD | 30.4% |
| 2006 Q1 | 100.88 Million USD | 13.22% |
| 2005 Q4 | 89.1 Million USD | 18.09% |
| 2005 Q3 | 75.45 Million USD | 16.35% |
| 2005 Q2 | 64.85 Million USD | 6.07% |
| 2005 Q1 | 61.14 Million USD | 9.58% |
| 2005 FY | 89.1 Million USD | 59.7% |
| 2004 FY | 55.79 Million USD | 12.98% |
| 2004 Q4 | 55.79 Million USD | -2.88% |
| 2004 Q3 | 57.45 Million USD | 1.04% |
| 2004 Q2 | 56.86 Million USD | 1.59% |
| 2004 Q1 | 55.97 Million USD | 13.34% |
| 2003 Q3 | 49.3 Million USD | 8.55% |
| 2003 FY | 49.38 Million USD | 19.95% |
| 2003 Q2 | 45.42 Million USD | 0.75% |
| 2003 Q1 | 45.08 Million USD | 9.5% |
| 2003 Q4 | 49.38 Million USD | 0.16% |
| 2002 Q2 | 33.47 Million USD | 3.18% |
| 2002 Q3 | 33.68 Million USD | 0.6% |
| 2002 Q4 | 41.17 Million USD | 22.25% |
| 2002 FY | 41.17 Million USD | 37.27% |
| 2002 Q1 | 32.44 Million USD | 8.18% |
| 2001 Q2 | 19.79 Million USD | 21.72% |
| 2001 Q1 | 16.25 Million USD | 2.89% |
| 2001 FY | 29.99 Million USD | 89.81% |
| 2001 Q4 | 29.99 Million USD | 4.6% |
| 2001 Q3 | 28.67 Million USD | 44.89% |
| 2000 Q2 | 15.9 Million USD | 13.57% |
| 2000 FY | 15.8 Million USD | 47.68% |
| 2000 Q1 | 14 Million USD | 30.84% |
| 2000 Q4 | 15.8 Million USD | -9.37% |
| 2000 Q3 | 17.43 Million USD | 9.65% |
| 1999 Q3 | 10 Million USD | -5.66% |
| 1999 FY | 10.7 Million USD | 40.79% |
| 1999 Q1 | 9.4 Million USD | 23.68% |
| 1999 Q2 | 10.6 Million USD | 12.77% |
| 1999 Q4 | 10.7 Million USD | 7.0% |
| 1998 Q4 | 7.6 Million USD | 5.56% |
| 1998 FY | 7.6 Million USD | 31.03% |
| 1998 Q2 | 7.6 Million USD | 20.63% |
| 1998 Q3 | 7.2 Million USD | -5.26% |
| 1998 Q1 | 6.3 Million USD | 8.62% |
| 1997 Q3 | 5.2 Million USD | -8.77% |
| 1997 FY | 5.8 Million USD | -4.92% |
| 1997 Q1 | 6.1 Million USD | 0.0% |
| 1997 Q2 | 5.7 Million USD | -6.56% |
| 1997 Q4 | 5.8 Million USD | 11.54% |
| 1996 FY | 6.1 Million USD | 38.64% |
| 1996 Q3 | 6.1 Million USD | 0.0% |
| 1996 Q4 | 6.1 Million USD | 0.0% |
| 1995 FY | 4.4 Million USD | 340.0% |
| 1995 Q4 | 4.4 Million USD | 0.0% |
| 1994 FY | 1 Million USD | 0.0% |
| 1994 Q4 | 1 Million USD | 0.0% |
| 1993 Q4 | 1 Million USD | 0.0% |
| 1993 FY | 1 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Phreesia, Inc. | - USD | -Infinity% |
| Accuray Incorporated | 138.32 Million USD | -494.438% |
| Align Technology, Inc. | 296.9 Million USD | -176.943% |
| Elevance Health Inc. | -46.33 Billion USD | 101.775% |
| AxoGen, Inc. | 23.02 Million USD | -3471.894% |
| Boston Scientific Corporation | 2.48 Billion USD | 66.898% |
| CVS Health Corporation | 18.02 Billion USD | 95.438% |
| Cardinal Health, Inc. | 14.95 Billion USD | 94.503% |
| Centene Corporation | - USD | -Infinity% |
| DaVita Inc. | 143.1 Million USD | -474.578% |
| HCA Healthcare, Inc. | 2.02 Billion USD | 59.315% |
| Hologic, Inc. | 679.8 Million USD | -20.955% |
| Humana Inc. | - USD | -Infinity% |
| IDEXX Laboratories, Inc. | 380.28 Million USD | -116.221% |
| Laboratory Corporation of America Holdings | 474.6 Million USD | -73.251% |
| Masimo Corporation | 545 Million USD | -50.872% |
| McKesson Corporation | 21.13 Billion USD | 96.11% |
| Patterson Companies, Inc. | 782.89 Million USD | -5.026% |
| Quest Diagnostics Incorporated | 190 Million USD | -332.763% |
| Henry Schein, Inc. | 1.81 Billion USD | 54.697% |
| Teladoc Health, Inc. | 29.51 Million USD | -2686.06% |
| Universal Health Services, Inc. | 216.98 Million USD | -278.938% |
| Veeva Systems Inc. | - USD | -Infinity% |
| Baxter International Inc. | 2.82 Billion USD | 70.883% |
| Becton, Dickinson and Company | 3.27 Billion USD | 74.878% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | 32.636% |
| Danaher Corporation | 2.59 Billion USD | 68.302% |
| Stryker Corporation | 4.84 Billion USD | 83.022% |
| Medtronic plc | 5.21 Billion USD | 84.239% |